Ignite Creation Date:
2024-05-06 @ 4:00 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02422199
Status:
UNKNOWN
Last Update Posted:
2018-07-09
First Post:
2015-04-16
Brief Title:
A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2Metastatic Breast Cancer Who Have Prior Received Anthracyclin Taxane or Trastuzumab
Sponsor:
Organization:
Jiangsu HengRui Medicine Co Ltd